ALUNBRIG emballage départ 7x90,21x180mg 28 pce

7680667380078 CH-66738 L01ED04 07.16.1.

Active substances:

ALUNBRIG emballage départ 7x90,21x180mg 28 pce
ALUNBRIG emballage départ 7x90,21x180mg 28 pce
ALUNBRIG emballage départ 7x90,21x180mg 28 pce
1 / 3
google

Details

Product number
6673804
CPT
-
Packaging group
7 + 21
Unit
Tablette(n)
Composition
I) 90 mg: brigatinibum 90 mg, lactosum monohydricum 168.17 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.378 - 0.567 mg, silica hydrophobica colloidalis, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), E 171 pro compresso obducto. II) 180 mg: brigatinibum 180 mg, lactosum monohydricum 336.33 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.756 - 0.1134 mg, silica hydrophobica colloidalis, magnesii stearas, Überzug: talcum, macrogolum 3350, poly(alcohol vinylicus), E 171 pro compresso obducto.

Articles (1)

Alunbrig 90 mg, 180 mg, Filmtabletten
Filmtabletten
7 + 21
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/06/2026
Patient information leaflet
Français
24/06/2026
Patient information leaflet
Italien
24/06/2026
Professional SmPC
Allemand
24/06/2026
Professional SmPC
Français
24/06/2026
Professional SmPC
Italien
24/06/2026

Detailed composition

Substance Quantity Type Category
brigatinibum
90.0 MG Substance Wirkstoff (Principe actif)
brigatinibum
180.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
336.33 MG Substance HBESI
lactosum monohydricum
168.17 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
carboxymethylamylum natricum A
- Substance HNIDK
carboxymethylamylum natricum A
- Substance HNIDK
natrium
- Substance HBESI
natrium
- Substance HBESI
silica hydrophobica colloidalis
- Substance HNIDK
silica hydrophobica colloidalis
- Substance HNIDK
magnesii stearas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
talcum
- Substance HNIDK
talcum
- Substance HNIDK
macrogolum 3350
- Substance HNIDK
macrogolum 3350
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK

Reimbursement information

Public price
CHF 4730.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2021

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
66738
Drug name
Alunbrig, Filmtabletten
Galenic form
FILM
ATC Code
L01ED04
Authorization status
Z
Dispensation category
A
First authorization
04/05/2021
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
nicht-kleinzelliges Lungenkarzinom (NSCLC)

Packaging details

Description (FR)
ALUNBRIG emballage départ 7x90,21x180mg 28 pce
Description (DE)
ALUNBRIG Starterpackung 7x90,21x180mg 28 Stk
Market launch
04/05/2021
Narcotic (BTM)
No

Other packaging sizes

ALUNBRIG cpr pell 30 mg 28 pce
28 TABL
View
ALUNBRIG cpr pell 90 mg 7 pce
7 TABL
View
ALUNBRIG cpr pell 90 mg 28 pce
28 TABL
View
ALUNBRIG cpr pell 180 mg 28 pce
28 TABL
View
Buy us a coffee Explore the data